Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:28:18.632Z.
Calculation as of: 2026-10-06T16:28:18.632Z.
Quote observation: 2026-10-06T16:24:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca628ff6f55b6345e2cefca22780bd34dfabddebf8a5c62bf0c86d2d29f40561
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Phio Pharmaceuticals Corp.
Market Cap
$11.49M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.26M
Free Cash Flow Yield
N/A
TTM Avg
42.18%
3Y Avg
42.18%
5Y Avg
42.18%
Market Cap
$11.19M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.12M
Free Cash Flow Yield
N/A
TTM Avg
10.32%
3Y Avg
10.32%
5Y Avg
10.32%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.49M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.54M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.40M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.26M | N/A | 42.18% | 42.18% | 42.18% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.19M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.16M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.88M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.12M | N/A | 10.32% | 10.32% | 10.32% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.29M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
